Abstral and Septic shock - a phase IV clinical study of FDA data

Summary:

Septic shock is reported as a side effect among people who take Abstral (fentanyl citrate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Intelence, and have Atypical mycobacterial infection.

The phase IV clinical study analyzes which people have Septic shock when taking Abstral. It is created by eHealthMe based on reports of 1,388 people who have side effects when taking Abstral from the FDA, and is updated regularly.

What is Abstral?

Abstral has active ingredients of fentanyl citrate. eHealthMe is studying from 1,390 Abstral users. Check the latest studies of Abstral.

What is Septic shock?

Septic shock (shock due to blood infection) is found to be associated with 1,745 drugs and 3,392 conditions by eHealthMe. Check the latest studies of Septic shock.

On Jul, 13, 2026

1,388 people reported to have side effects when taking Abstral.
Among them, 16 people (1.15%) have Septic shock.

Among these 16 people:

How long have people been on Abstral when they have Septic shock? *

What is the gender of people who have Septic shock when taking Abstral? *

female: 62.5 %
male: 37.5 %

What is the age of people who have Septic shock when taking Abstral? *

What are other drugs people take besides Abstral? *

Myambutol: 5 people, 31.25%
Isentress: 5 people, 31.25%
Intelence: 5 people, 31.25%
Vfend: 4 people, 25.00%
Allopurinol: 3 people, 18.75%
Oxycontin: 3 people, 18.75%
Zolpidem Tartrate: 3 people, 18.75%
Lidocaine Hydrochloride: 3 people, 18.75%
Ursodiol: 3 people, 18.75%
Bactrim: 3 people, 18.75%

What are other side effects people have besides Septic shock? *

Hepatic Failure (liver failure): 5 people, 31.25%
Myocarditis (inflammation of heart muscle myocardium): 5 people, 31.25%
Heart Attack: 5 people, 31.25%
Cardiac Failure Acute: 4 people, 25.00%
Cardiac Failure: 3 people, 18.75%
Hypokalemia (low potassium): 2 people, 12.50%
Bone Marrow Failure: 2 people, 12.50%
Diarrhea: 2 people, 12.50%
Febrile Neutropenia (fever with reduced white blood cells): 2 people, 12.50%
Fever: 2 people, 12.50%

What are the existing conditions these people have? *

Atypical Mycobacterial Infection (infections caused by several types of mycobacterium similar to the germ that causes tuberculosis): 4 people, 25.00%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 3 people, 18.75%
Bone Pain: 3 people, 18.75%
Depression: 3 people, 18.75%
Acute Lymphocytic Leukaemia Recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent): 2 people, 12.50%
Pain: 2 people, 12.50%
Oedema (fluid collection in tissue): 2 people, 12.50%
Lung Infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung): 2 people, 12.50%
Hiv Infection: 2 people, 12.50%
Epstein-Barr Virus Infection: 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Abstral and have Septic shock?

- Check whether Septic shock is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Abstral:

Abstral (1,390 reports)

Septic shock treatments and more:

Septic shock (51,128 reports)

Browse all side effects of Abstral:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Septic shock:

Septic shock (1,745 drugs)

Browse all the conditions that are associated with Septic shock:

Septic shock (3,392 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fentanyl citrate (the active ingredients of Abstral) and Abstral (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.